Mark A Osborne

Title: Mark A. Osborne: Innovator in Protein-Protein Interaction Detection

Introduction

Mark A. Osborne, located in South Brunswick, NJ, is a distinguished inventor known for his contributions to the scientific community. He holds a patent that provides innovative methods for studying protein-protein interactions, which are essential for understanding various biological processes. His work is significant in the field of molecular biology and has potential applications in drug discovery and development.

Latest Patents

Mark A. Osborne holds a patent titled "Method to detect protein-protein interactions." This patent outlines methods for studying protein interactions that involve posttranslational modifications of one protein. The uniqueness of this method lies in its ability to detect interactions by reconstituting the activity of a transcriptional activator, dependent on the interactions among three distinct proteins. The patent highlights the use of chimeric proteins that fuse transcriptional activation and DNA-binding domains with test proteins, enabling the detection of these critical interactions.

Career Highlights

Mark A. Osborne works at Hoffmann-La Roche Inc., a leading healthcare company known for its innovative approaches in pharmaceuticals and diagnostics. His role at the company involves developing methods that enhance our understanding of protein interactions, which can lead to breakthroughs in medical treatments and therapies. His dedication to research has positioned him as a key contributor in his field.

Collaborations

Throughout his career, Mark has collaborated with esteemed colleagues, including Stephen Dalton and Jarema Peter Kochan. Such collaborations highlight his commitment to teamwork and knowledge sharing, fostering an environment where innovative ideas can thrive and leading to impactful results in scientific research.

Conclusion

In summary, Mark A. Osborne’s contributions to the study of protein-protein interactions through his patented methods represent significant strides in the field of molecular biology. His work not only enhances our understanding of biological processes but also opens up new avenues for therapeutic development. With his ongoing research at Hoffmann-La Roche Inc. and valuable collaborations, Osborne continues to be a prominent figure in scientific innovation.